SEC Form 4 · accession 0001179110-17-003180
ABBOTT LABORATORIES · ABT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert E Funck
Officer — Vice President, Controller
Period of report
Feb 23, 2017
Accepted (ET)
Feb 24, 2017 · 5:28 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000001800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common shares without par value | Feb 23, 2017 | M | 25,500 | $26.6973 | A | 117,579 | D | |
| Common shares without par value | Feb 23, 2017 | S | 25,500 | $45.50 | D | 92,079 | D | |
| Profit Sharing TrustF1 | holding | — | — | — | 16,654 | I | Profit Sharing Trust | |
| Common shares without par valueF2 | holding | — | — | — | 500 | I | By Daughter | |
| Common shares without par valueF2 | holding | — | — | — | 500 | I | By Daughter |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option (right to buy)F3 | $26.6973 | Feb 23, 2017 | M | 25,500 | D | Feb 15, 2011 | Feb 14, 2018 | Common shares | 25,500 | 0 | D |
Explanation of responses
- F1Balance in the Abbott Laboratories Stock Retirement Trust as of February 23, 2017.
- F2The reporting person disclaims beneficial ownership of all securities held by his daughter.
- F3Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.
Remarks
These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).